Search Results < Yale Cancer Center

Yale Cancer Center

2643 results

News
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as CT Magazine Best Doctors
Connecticut Magazine has named 82 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2020 Best Doctors guide
4 Jun 2020
News
Doctors Urge the Public to Seek Help for Cancer Screenings as Sharp Decline in Care Means Thousands of Untreated Cases
In March and April just 97 cases of prostate cancer were diagnosed throughout Hartford Healthcare compared with 233 cases in 2019. The stark decline holds true for digestive cancers with a 42 percent decline in diagnoses and breast cancer with a 30 percent decline in diagnoses compared to the same period in 2019.
3 Jun 2020
News
Yale Cancer Center Scientists Reveal How Mutations in Metabolism Can Drive Cancers
Yale Cancer Center (YCC) scientists have identified mutations in metabolite-producing genes as a disruption of DNA repair.
3 Jun 2020
News
Smilow Torrington supports fellow healthcare workers and community
Smilow Cancer Hospital Care Center at Torrington, in collaboration with Agriventures Agway of Litchfield, provided a donation of flower and vegetable seed packets to the physicians, nurses, and staff at Charlotte Hungerford Hospital in Torrington.
2 Jun 2020
News
Drug Could Boost Survival From Lung Cancer Affecting Non-Smokers
The drug Tagrisso could offer hope to patients battling a form of lung cancer that typically hits people with little or no history of smoking, a new trial finds.
1 Jun 2020
News
Yale Cancer Center Announces Prestigious ASCO Awards
Five Yale Cancer Center physicians have received awards from Conquer Cancer, the American Society of Cancer Oncology Foundation. The grants are given in conjunction with the virtual scientific program of the 2020 ASCO Annual Meeting.
1 Jun 2020
News
New drugs make headway against lung, prostate, colon cancers
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear.
29 May 2020
News
Study Conducted at Yale Cancer Center Shows Clinical Evidence of Anti-Tumor Activity in Patients with Metastatic Castration-Resistant Prostate Cancer
Results of a clinical trial conducted by researchers at the Yale Cancer Center have shown that ARV-110, an androgen receptor PROTAC® protein degrader, demonstrates anti-tumor responses in patients with metastatic castration-resistant prostate cancer.
29 May 2020
News
Yale Cancer Center Investigator Shows Chemotherapy Combined with Low Doses of Radiotherapy Improves Survival for Patients with Rare Lymphoma
According to findings of a national study, the addition of low-dose, whole-brain radiotherapy (LD-WBRT) combined with chemotherapy improved progression-free survival (PFS) in patients with primary central nervous system lymphoma (PCNSL). These results are to be presented May 30 at 11:00 a.m., during the virtual Scientific Program at the annual meeting of the American Society of Clinical Oncology (ASCO).
28 May 2020
News
Encouraging New Data from Yale Cancer Center Shows Correlation to PD-L1 Expression from KEYNOTE-061
New findings led by Yale Cancer Center researchers show data sharing improved survival for patients with advanced gastric cancers. The data will be presented on May 30 at 11:00 a.m., during the virtual Scientific Program at the annual meeting of the American Society of Clinical Oncology (ASCO).
28 May 2020
News
Yale Cancer Center Study Shows Profound Benefit with Targeted Therapy for Patients with Early Stage NSCLC
According to findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery significantly improves disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations.
28 May 2020
News
Video: PARP Inhibition in Castration-resistant Prostate Cancer - Daniel Petrylak
Dr. Dan Petrylak joins Tom Keane to discuss PARP inhibition in castration-resistant prostate cancer. In this lecture, Dr. Petrylak discusses the germline DNA repair mutations involved in prostate cancer. This is a state of the art lecture establishing the rationale for the clinical trials evaluating PARP inhibitors in metastatic castration-resistant prostate cancer.
28 May 2020
News
Exploring the frontiers of immunity and healing
During a 1989 lecture at the Cold Spring Harbor Symposium on Quantitative Biology, Yale School of Medicine professor Charles Janeway, MD, hypothesized the existence of an innate immune system and special receptors on immune cells (currently known as toll-like receptors) that trigger the body's response to infection. Janeway's research later confirmed his insights, providing the foundation of future endeavors exploring the intricacies of the human immune response. New discoveries continue to reveal an exquisitely tuned immune system in which inflammatory responses and healing are initiated and regulated by known and unknown mechanisms.
27 May 2020
News
For cancer treatment and more, genetic-based precision medicine holds a lot of promise
For some doctors and researchers, precision medicine holds the promise of effective targeted diseases and chronic conditions, and, even more revolutionary, the chance to prevent illness before it arises.
26 May 2020
News
Health Care Heroes: Saluting Front-Line Workers in the Battle Against the Coronavirus
Kelly Gaffney and Kali Pelligrino, Clinic Nurses at Smilow Cancer Hospital, talk about their experiences caring for patients in the time of Covid-19.
26 May 2020
News
2020 Rise Award Winner, Jeanne Hendrickson, MD
Congratulations to Dr. Jeanne Hendrickson for being the 2020 RISE Award winner
26 May 2020
News
Patient Safety at Smilow Cancer Hospital
As we continue to face unprecedented times together, our patients, their families, and our caregivers remain our top priority.
25 May 2020
News
Dr. Roy Herbst Receives 2020 AACR Distinguished Public Service Award
Dr. Roy Herbst is honored as one of this year’s recipients of the 2020 American Association for Cancer Research Distinguished Public Service Award.
22 May 2020
News
Yale Cancer Disparities Firewall Project Receives Grants from the Bristol Myers Squibb Foundation to Fight COVID-19
Yale Cancer Center is pleased to announce that the Yale Cancer Disparities Firewall (Firewall) project has been awarded two grants from the Bristol Myers Squibb Foundation.
21 May 2020
News
Yale Cancer Center Study Demonstrates Impact of Both Inherited and Acquired Mutations on Cancer
The common belief that tumors arise via activation of a few genes that “drive” cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center researchers.
15 May 2020